Japan Protein Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Protein Sequencing Products and Protein Sequencing Services), By Application (Bio-therapeutics, Genetic Engineering, and Others), and Japan Protein Sequencing Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Sep 2025
REPORT ID SI15715
PAGES 243
REPORT FORMAT PathSoft

Japan Protein Sequencing Market Insights Forecasts to 2035

  • The Japan Protein Sequencing Market Size is expected to Grow at a CAGR of around 3.9% from 2025 to 2035
  • The Japan Protein Sequencing Market Size is expected to hold a significant share by 2035

Japan Protein Sequencing Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, The Japan Protein Sequencing Market Size is anticipated to hold a significant share by 2035, growing at a CAGR of 3.9% from 2025 to 2035. The protein sequencing market in Japan is driven by the growing use of mass spectrometry for automated protein sequencing systems. Furthermore, target based drug development is being conducted by biotechnology and pharmaceutical companies, particularly in established and emerging nations.

 

Market Overview

Protein sequencing is the process of determining the exact order of amino acids in a protein or peptide chain. Understanding protein composition, activity, and interconnects is aided by sequencing, as proteins are made up of separate amino acid sequences that determine their size and biological roles. The actual expressed molecule and its post-translational modifications are directly manifested by protein sequencing, as opposed to DNA sequencing, which reveals the genetic blueprint. Protein sequencing is mainly completed using mass spectrometry (MS) and Edman degradation. Only small chains can be identified through Edman degradation, a phased chemical process that finds amino acids from the N-terminal end of a peptide. Due to its high sensitivity, rapidity, and ability to evaluate large proteins more accurately, mass spectrometry has become a dominant technology. In many areas of study and business, protein sequencing is necessary. It helps in the development of targeted drugs, research into the causes of the disease, and the identification of biomarkers in biomedical science. Protein engineering, synthetic biology, and the manufacture of new therapeutic proteins are all made possible by sequencing in biotechnology. To confirm the protein structure and identify adulteration, it is also often used in forensic analysis, food science, and agriculture.

 

Report Coverage

This research report categorizes the market for the Japan protein sequencing market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan protein sequencing market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan protein sequencing market.

 

Japan Protein Sequencing Market Report Coverage

Report CoverageDetails
Base Year:2024
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :3.9%
Historical Data for:2020-2023
No. of Pages:243
Tables, Charts & Figures:120
Segments covered:By Product & Service, By Application and COVID-19 Impact Analysis
Companies covered::Shimadzu corporation, Takara Bio Inc, GE Healthcare Japan, JEOL Ltd., Horiba, Ltd., Resonac, TOMY Digital Biology Co., Ltd, Cosmo Bio Co., Ltd., and Others
Pitfalls & Challenges:COVID-19 Empact,Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The protein sequencing market in Japan is driven by the emphasis on the need for mass spectrometry development, proteomics research, and individual medicine. More and more use of sequencing by drug and biotech businesses for quality control, biomarker identification, and drug discovery. In addition, the Government aid, technological progress, forensic analysis, food security, and increasing uses in agriculture are also expanding markets.

 

Restraining Factors

The protein sequencing market is mostly constrained by the fact that widely adopting sequencing technologies is prohibited by their high cost, the preparation of complex samples, and the requirement of special knowledge. Also, the lack of skilled professionals and the availability of alternative proteomics tools further restrict growth

 

Market Segmentation

The Japan protein sequencing market share is classified into product & Service and application.  

 

  • The protein sequencing services segment is expected to grow significantly over the forecast period.   

The Japan protein sequencing market is segmented by product & service into protein sequencing products and protein sequencing services. Among these, the protein sequencing services segment is expected to grow significantly over the forecast period. This is due to the growing complexities of protein analysis and the expensive sequencing infrastructure. Furthermore, service offerings have been improved by technical developments like next-generation sequencing and mass spectrometry.

 

  • The biotherapeutics segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Japan protein sequencing market is segmented by application into bio-therapeutics, genetic engineering, and others. Among these, the biotherapeutics segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because the pharmaceutical companies are putting more of an emphasis on creating novel biotherapeutics, especially monoclonal antibodies.  The treatment of many illnesses, such as autoimmune diseases and cancer, depends on these therapeutic proteins.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan protein sequencing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Shimadzu corporation
  • Takara Bio Inc
  • GE Healthcare Japan
  • JEOL Ltd.
  • Horiba, Ltd.
  • Resonac
  • TOMY Digital Biology Co., Ltd
  • Cosmo Bio Co., Ltd.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan protein sequencing market based on the below-mentioned segments:

 

Japan Protein Sequencing Market, By Product & Services

  • Protein Sequencing Products
  • Protein Sequencing Services

 

Japan Protein Sequencing Market, By Application

  • Bio-therapeutics
  • Genetic Engineering
  • Others

Frequently Asked Questions (FAQ)

  • Q: What is the base year considered in the Japan protein sequencing market report?
    A: The base year considered is 2024.
  • Q: What historical period does the report cover?
    A: The report covers historical data from 2020 to 2023.
  • Q: What is the forecast period for the Japan protein sequencing market?
    A: The forecast period is from 2025 to 2035.
  • Q: What is the expected CAGR of the Japan protein sequencing market during 2025–2035?
    A: The market is expected to grow at a CAGR of 3.9%.
  • Q: Which segment is expected to grow significantly by product & services?
    A: The protein sequencing services segment is expected to grow significantly during the forecast period.
  • Q: Which application dominated the market in 2024?
    A: The biotherapeutics segment dominated the market in 2024.
  • Q: What are the key driving factors for the Japan protein sequencing market?
    A: Growth in proteomics research, personalized medicine, drug discovery, and technological advancements in sequencing.
  • Q: What are the major restraints for the Japan protein sequencing market?
    A: High costs, complex sample preparation, lack of skilled professionals, and availability of alternative tools.
  • Q: Who are the leading companies operating in the Japan protein sequencing market?
    A: Key players include Shimadzu Corporation, Takara Bio Inc., JEOL Ltd., Horiba Ltd., Resonac, GE Healthcare Japan, TOMY Digital Biology Co., and Cosmo Bio Co., Ltd., and Others.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies